Cantabio Pharmaceuticals Inc.

Tackling Neurodegenerative Diseases Head On

Cantabio Pharmaceuticals aims to slow, stop and even prevent the onset and progression of degenerative brain diseases such as Alzheimer’s and Parkinson’s disease.

Learn More

Drug Discovery Research

Cantabio strategically integrates therapeutic focus, target family biophysics, novel drug discovery technologies and expertise into innovative drug discovery approaches.

View Video

Cantabio in Biocentury Innovations

Cantabio Pharmaceuticals’ DJ-1 pharmacological chaperone program has been featured in Biocentury Innovations as the cover article for October 20th.

Read Article
Latest News Cantabio Announces Publication of Novel Study Demonstrating the Importance of the DJ-1 Protein in the Onset and Pathology of Alzheimer's and Parkinson's disease Read More